Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Graves Disease Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Anti-Thyroid Drugs
1.2.3 Lodine &Lodides
1.2.4 Radioactive Lodine
1.2.5 Lonic Inhibitors
1.3 Market by Application
1.3.1 Global Graves Disease Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Graves Disease Market Perspective (2018-2033)
2.2 Graves Disease Growth Trends by Region
2.2.1 Global Graves Disease Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Graves Disease Historic Market Size by Region (2018-2023)
2.2.3 Graves Disease Forecasted Market Size by Region (2024-2033)
2.3 Graves Disease Market Dynamics
2.3.1 Graves Disease Industry Trends
2.3.2 Graves Disease Market Drivers
2.3.3 Graves Disease Market Challenges
2.3.4 Graves Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Graves Disease Players by Revenue
3.1.1 Global Top Graves Disease Players by Revenue (2018-2023)
3.1.2 Global Graves Disease Revenue Market Share by Players (2018-2023)
3.2 Global Graves Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Graves Disease Revenue
3.4 Global Graves Disease Market Concentration Ratio
3.4.1 Global Graves Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Graves Disease Revenue in 2022
3.5 Graves Disease Key Players Head office and Area Served
3.6 Key Players Graves Disease Product Solution and Service
3.7 Date of Enter into Graves Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Graves Disease Breakdown Data by Type
4.1 Global Graves Disease Historic Market Size by Type (2018-2023)
4.2 Global Graves Disease Forecasted Market Size by Type (2024-2033)
5 Graves Disease Breakdown Data by Application
5.1 Global Graves Disease Historic Market Size by Application (2018-2023)
5.2 Global Graves Disease Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Graves Disease Market Size (2018-2033)
6.2 North America Graves Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Graves Disease Market Size by Country (2018-2023)
6.4 North America Graves Disease Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Graves Disease Market Size (2018-2033)
7.2 Europe Graves Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Graves Disease Market Size by Country (2018-2023)
7.4 Europe Graves Disease Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Graves Disease Market Size (2018-2033)
8.2 Asia-Pacific Graves Disease Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Graves Disease Market Size by Region (2018-2023)
8.4 Asia-Pacific Graves Disease Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Graves Disease Market Size (2018-2033)
9.2 Latin America Graves Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Graves Disease Market Size by Country (2018-2023)
9.4 Latin America Graves Disease Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Graves Disease Market Size (2018-2033)
10.2 Middle East & Africa Graves Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Graves Disease Market Size by Country (2018-2023)
10.4 Middle East & Africa Graves Disease Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Graves Disease Introduction
11.1.4 Abbott Laboratories Revenue in Graves Disease Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Detail
11.2.2 GlaxoSmithKline plc Business Overview
11.2.3 GlaxoSmithKline plc Graves Disease Introduction
11.2.4 GlaxoSmithKline plc Revenue in Graves Disease Business (2018-2023)
11.2.5 GlaxoSmithKline plc Recent Development
11.3 Merck & Co
11.3.1 Merck & Co Company Detail
11.3.2 Merck & Co Business Overview
11.3.3 Merck & Co Graves Disease Introduction
11.3.4 Merck & Co Revenue in Graves Disease Business (2018-2023)
11.3.5 Merck & Co Recent Development
11.4 Pfizer, Inc
11.4.1 Pfizer, Inc Company Detail
11.4.2 Pfizer, Inc Business Overview
11.4.3 Pfizer, Inc Graves Disease Introduction
11.4.4 Pfizer, Inc Revenue in Graves Disease Business (2018-2023)
11.4.5 Pfizer, Inc Recent Development
11.5 RLC LABS
11.5.1 RLC LABS Company Detail
11.5.2 RLC LABS Business Overview
11.5.3 RLC LABS Graves Disease Introduction
11.5.4 RLC LABS Revenue in Graves Disease Business (2018-2023)
11.5.5 RLC LABS Recent Development
11.6 AbbVie, Inc
11.6.1 AbbVie, Inc Company Detail
11.6.2 AbbVie, Inc Business Overview
11.6.3 AbbVie, Inc Graves Disease Introduction
11.6.4 AbbVie, Inc Revenue in Graves Disease Business (2018-2023)
11.6.5 AbbVie, Inc Recent Development
11.7 Mylan N.V
11.7.1 Mylan N.V Company Detail
11.7.2 Mylan N.V Business Overview
11.7.3 Mylan N.V Graves Disease Introduction
11.7.4 Mylan N.V Revenue in Graves Disease Business (2018-2023)
11.7.5 Mylan N.V Recent Development
11.8 Allergan, plc
11.8.1 Allergan, plc Company Detail
11.8.2 Allergan, plc Business Overview
11.8.3 Allergan, plc Graves Disease Introduction
11.8.4 Allergan, plc Revenue in Graves Disease Business (2018-2023)
11.8.5 Allergan, plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Graves Disease Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Anti-Thyroid Drugs
Table 3. Key Players of Lodine &Lodides
Table 4. Key Players of Radioactive Lodine
Table 5. Key Players of Lonic Inhibitors
Table 6. Global Graves Disease Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Graves Disease Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Graves Disease Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Graves Disease Market Share by Region (2018-2023)
Table 10. Global Graves Disease Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Graves Disease Market Share by Region (2024-2033)
Table 12. Graves Disease Market Trends
Table 13. Graves Disease Market Drivers
Table 14. Graves Disease Market Challenges
Table 15. Graves Disease Market Restraints
Table 16. Global Graves Disease Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Graves Disease Market Share by Players (2018-2023)
Table 18. Global Top Graves Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Graves Disease as of 2022)
Table 19. Ranking of Global Top Graves Disease Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Graves Disease Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Graves Disease Product Solution and Service
Table 23. Date of Enter into Graves Disease Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Graves Disease Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Graves Disease Revenue Market Share by Type (2018-2023)
Table 27. Global Graves Disease Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Graves Disease Revenue Market Share by Type (2024-2033)
Table 29. Global Graves Disease Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Graves Disease Revenue Market Share by Application (2018-2023)
Table 31. Global Graves Disease Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Graves Disease Revenue Market Share by Application (2024-2033)
Table 33. North America Graves Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Graves Disease Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Graves Disease Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Graves Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Graves Disease Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Graves Disease Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Graves Disease Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Graves Disease Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Graves Disease Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Graves Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Graves Disease Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Graves Disease Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Graves Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Graves Disease Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Graves Disease Market Size by Country (2024-2033) & (US$ Million)
Table 48. Abbott Laboratories Company Detail
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Graves Disease Product
Table 51. Abbott Laboratories Revenue in Graves Disease Business (2018-2023) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. GlaxoSmithKline plc Company Detail
Table 54. GlaxoSmithKline plc Business Overview
Table 55. GlaxoSmithKline plc Graves Disease Product
Table 56. GlaxoSmithKline plc Revenue in Graves Disease Business (2018-2023) & (US$ Million)
Table 57. GlaxoSmithKline plc Recent Development
Table 58. Merck & Co Company Detail
Table 59. Merck & Co Business Overview
Table 60. Merck & Co Graves Disease Product
Table 61. Merck & Co Revenue in Graves Disease Business (2018-2023) & (US$ Million)
Table 62. Merck & Co Recent Development
Table 63. Pfizer, Inc Company Detail
Table 64. Pfizer, Inc Business Overview
Table 65. Pfizer, Inc Graves Disease Product
Table 66. Pfizer, Inc Revenue in Graves Disease Business (2018-2023) & (US$ Million)
Table 67. Pfizer, Inc Recent Development
Table 68. RLC LABS Company Detail
Table 69. RLC LABS Business Overview
Table 70. RLC LABS Graves Disease Product
Table 71. RLC LABS Revenue in Graves Disease Business (2018-2023) & (US$ Million)
Table 72. RLC LABS Recent Development
Table 73. AbbVie, Inc Company Detail
Table 74. AbbVie, Inc Business Overview
Table 75. AbbVie, Inc Graves Disease Product
Table 76. AbbVie, Inc Revenue in Graves Disease Business (2018-2023) & (US$ Million)
Table 77. AbbVie, Inc Recent Development
Table 78. Mylan N.V Company Detail
Table 79. Mylan N.V Business Overview
Table 80. Mylan N.V Graves Disease Product
Table 81. Mylan N.V Revenue in Graves Disease Business (2018-2023) & (US$ Million)
Table 82. Mylan N.V Recent Development
Table 83. Allergan, plc Company Detail
Table 84. Allergan, plc Business Overview
Table 85. Allergan, plc Graves Disease Product
Table 86. Allergan, plc Revenue in Graves Disease Business (2018-2023) & (US$ Million)
Table 87. Allergan, plc Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Graves Disease Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Graves Disease Market Share by Type: 2022 VS 2033
Figure 3. Anti-Thyroid Drugs Features
Figure 4. Lodine &Lodides Features
Figure 5. Radioactive Lodine Features
Figure 6. Lonic Inhibitors Features
Figure 7. Global Graves Disease Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Graves Disease Market Share by Application: 2022 VS 2033
Figure 9. Hospital Pharmacy Case Studies
Figure 10. Online Pharmacy Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Graves Disease Report Years Considered
Figure 13. Global Graves Disease Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Graves Disease Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Graves Disease Market Share by Region: 2022 VS 2033
Figure 16. Global Graves Disease Market Share by Players in 2022
Figure 17. Global Top Graves Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Graves Disease as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Graves Disease Revenue in 2022
Figure 19. North America Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Graves Disease Market Share by Country (2018-2033)
Figure 21. United States Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Graves Disease Market Share by Country (2018-2033)
Figure 25. Germany Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Graves Disease Market Share by Region (2018-2033)
Figure 33. China Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Graves Disease Market Share by Country (2018-2033)
Figure 41. Mexico Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Graves Disease Market Share by Country (2018-2033)
Figure 45. Turkey Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Graves Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Abbott Laboratories Revenue Growth Rate in Graves Disease Business (2018-2023)
Figure 48. GlaxoSmithKline plc Revenue Growth Rate in Graves Disease Business (2018-2023)
Figure 49. Merck & Co Revenue Growth Rate in Graves Disease Business (2018-2023)
Figure 50. Pfizer, Inc Revenue Growth Rate in Graves Disease Business (2018-2023)
Figure 51. RLC LABS Revenue Growth Rate in Graves Disease Business (2018-2023)
Figure 52. AbbVie, Inc Revenue Growth Rate in Graves Disease Business (2018-2023)
Figure 53. Mylan N.V Revenue Growth Rate in Graves Disease Business (2018-2023)
Figure 54. Allergan, plc Revenue Growth Rate in Graves Disease Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed